MyGenomeRx

Curated by Signal

Provider of a platform for genomic testing

Overview

Provider of a platform for genomic testing. The company's flagship product includes MyGenomeRx which analyze individuals' DNA data to provide genotype and allele information. This can be used to determine metabolic phenotypes for dose adjustment/optimization. It provides services to analyze drug-drug interaction, personalized pharmacogenomics, and gene-drug interaction.

Key facts

Founded: 2020
Headquarters: Palatine, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Cirrus Bio
Developer of multi omic solutions for the diagnosis and management of diseases
Life Sciences TechnologyPhoenix, United States
JPI Healthcare
Portfolio of X-ray and radiology equipment
Life Sciences TechnologyPlainview, United States
Macromoltek
Provider of an antibody modeling & analysis tool for the biotechnology and pharmaceutical industries
Life Sciences TechnologyAustin, United States

About MyGenomeRx

What does MyGenomeRx do?

Provider of a platform for genomic testing.

Where is MyGenomeRx headquartered?

MyGenomeRx is headquartered in Palatine, United States.

When was MyGenomeRx founded?

MyGenomeRx was founded in 2020.

Which sector is MyGenomeRx in?

MyGenomeRx operates in Life Sciences Technology.

Who are MyGenomeRx's competitors?

Companies similar to MyGenomeRx include Cirrus Bio, JPI Healthcare, and Macromoltek.